Summary of Key Points from the Conference Call Industry Overview - **Industry**: China Autos & Shared Mobility - **Focus**: Autonomous Driving (AD) and Electric Vehicles (EVs) Core Insights 1. **Tesla's FSD Rollout in China**: Tesla's Full Self-Driving (FSD) rollout in China could receive approval as early as February 2026, with discussions in the final stages, although stringent data scrutiny may cause delays [1][2][3] 2. **Impact on AD Supply Chain**: The potential approval of Tesla's FSD is expected to positively impact the AD supply chain and robotaxi players, potentially accelerating Level 3 (L3) license approvals and expanding Level 4 (L4) robotaxi operations [2][3] 3. **Regulatory Environment**: Improved Sino-US relations may facilitate regulatory approval for FSD in China, but local data capture and cloud access remain sensitive issues that require careful management [3][4] 4. **L3 Technology Adoption**: The Chinese government has been granting L3 AD permits since December 2025, with several local brands like Chang'an and XPeng receiving approvals. The rollout of Tesla's FSD could significantly boost the entire AD ecosystem in China [4][6] 5. **AI Technology Implications**: Tesla's suite of AI technologies could catalyze advancements in China's AI supply chain, positioning the country for long-term growth in this sector [5] 6. **Local Competition**: Local brands are preparing for the competitive impact of Tesla's FSD rollout, with expectations that major Chinese players will accelerate their own L3 development to maintain market share [6] Additional Important Points 1. **Stock Recommendations**: Preferred stocks in the China AD space include Hesai (HSAI.O) and WeRide (WRD.O), with Horizon Robotics (9660.HK) and Desay SV (002920.SZ) expected to benefit from faster adoption of Level 2 and above technologies [2][8] 2. **Market Dynamics**: The potential for Tesla's FSD to act as a quasi-robotaxi does not guarantee a smooth rollout for robotaxis in China, as this would involve more complex data collection and regulatory challenges [10] 3. **Valuation Methodology**: The report includes various valuation methodologies for companies like Huizhou Desay SV and Horizon Robotics, with key assumptions regarding WACC and growth rates [11][12][13] This summary encapsulates the critical insights and implications for the China Autos & Shared Mobility industry, particularly focusing on Tesla's developments and their potential impact on local competitors and the broader market.

Summary of Key Points from Morgan Stanley Asia's Thematic Opportunities (3Q25) Industry Overview - **Industry**: Various sectors within the Asia Pacific region, focusing on emerging investment themes and opportunities identified by Morgan Stanley's research department. Core Themes and Investment Opportunities 1. **Future of Energy** - Global solar market expected to see gross margins for integrated module players turn positive by 2026-27 due to anti-involution reforms [3][3] - Japan's natural gas demand projected to grow at a CAGR of +0.8% from 2023-2031, with LNG imports from the US expected to rise by +14% [3][3] - Global new nuclear capacity anticipated to reach 587GW by 2050, with significant growth in Asia, particularly China and India [3][3] 2. **Tech Diffusion** - AI data centers projected to consume up to 1,068 billion liters of water annually by 2028, an 11x increase from 2024, driven by cooling and electricity generation needs [3][3] - AI NAND market expected to account for 34% of the global NAND market by 2029, adding an incremental US$29 billion to the total addressable market [3][3] 3. **Multipolar World** - Defense spending in Asia (South Korea, Japan, Singapore, India) projected to expand at a 12% CAGR to US$354 billion by 2029, matching China's defense budget [3][3] - Vehicles with Level 2+ all-scenario smart driving expected to reach 28% of unit sales by 2030, up from 8% in 2024, with a global ADAS/AD market size estimated at US$200 billion by 2030 [3][3] 4. **Capital Market Reform** - MSCI China's ROE expected to rise to 13.3% by 2030, supported by policy execution and structural reforms [3][3] - Singapore's equity market reforms could drive ROE to 14% from 12%, potentially doubling market cap by 2030 [3][3] 5. **Longevity** - Innovative drug sales projected to comprise 53% of China's pharmaceutical market by 2030, up from 29% in 2023, with a CAGR of 21% from 2024 to 2030 [3][3] Additional Insights - **Water Consumption Risks**: AI's water consumption poses high local risks, especially in data center hubs facing water scarcity, highlighting the need for strategic investments in water-efficient technologies [27][27] - **Supply Chain Dynamics**: The report discusses the ongoing reorientation of supply chains due to geopolitical tensions, particularly between the US and China, and the shift towards onshoring production in the US for high-end products [56][56] - **Defense Industry Outlook**: The report emphasizes the expected super-cycle in Korea's defense industry, driven by rising global defense budgets and the need for modernization [64][64] Key Stock Implications - **Top Picks**: The report identifies several companies across various themes, including: - **Tech Diffusion**: KIOXIA, Samsung Electronics, and Hanwha Aerospace [12][12] - **Future of Energy**: Reliance Industries and Gulf Development PCL [12][12] - **Longevity**: Jiangsu Hengrui and Hansoh Pharmaceutical Group [12][12] This summary encapsulates the key themes and insights from Morgan Stanley's thematic opportunities report, highlighting potential investment avenues and risks within the Asia Pacific region.